Caladrius Biosciences מכפיל רווח שנתי 2024

מה עושה Caladrius Biosciences?

Caladrius Biosciences Inc was founded in 1980 as a pharmaceutical biotechnology company and is headquartered in Basking Ridge, New Jersey. The company focuses on developing cellular therapies for the treatment of serious diseases. Caladrius Biosciences aims to improve the lives of patients with unmet medical needs by developing novel and innovative therapies based on neuroscientific, immunological, and regenerative approaches. The business model of Caladrius Biosciences is based on researching and developing products that focus on the needs of patients. The goal is to concentrate on innovative and groundbreaking therapies that can treat diseases that have not been adequately treated before. The company has developed a portfolio of groundbreaking products based on stem cell, immune, and regenerative therapies. Caladrius Biosciences has three different business areas: - The first business area is its subsidiary PCT, LLC, which offers clinical manufacturing services in the field of clinical cell therapies. The subsidiary provides a scalable platform for the production of individual cell-based therapies. - The second business area is conducting clinical trials, including in the field of cardiovascular diseases. Caladrius Biosciences collaborates closely with clinics, doctors, and other professionals to demonstrate the potential of its own products through clinical studies. - The third area is the development of innovative therapies for diseases that previously could not be treated. The company is working on regenerative, immunological, and stem cell therapies. Caladrius has various products in development based on novel technologies, such as stem cell therapy. The company focuses on cardiovascular diseases, autoimmune diseases, and cancer. One of the flagship products of the company is CLBS201, which is a stem cell treatment for coronary heart disease. It is an autologous cell-based product derived from a patient's bone marrow and is used in combination with angioplasty, a minimally invasive surgical procedure to widen narrowed or blocked blood vessels. In summary, Caladrius Biosciences Inc is a leading biopharmaceutical company that focuses on developing innovative stem cell and immune therapies for the treatment of serious diseases. The company prioritizes the needs of patients and has established a unique position in the regenerative and cell-based therapy industry. Caladrius Biosciences pursues a long-term and sustainable growth model by relying on innovative technologies and clinical trials to continue developing groundbreaking products. In short, Caladrius Biosciences tirelessly works to improve the lives of people and cure diseases that were previously considered incurable. Caladrius Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.